|
PPPDE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74105174721717E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.25199969783318E-10 |
| Normal-vs-Stage2 |
2.57079999510523E-08 |
| Normal-vs-Stage3 |
1.17789999976026E-10 |
| Normal-vs-Stage4 |
2.15909999878861E-08 |
| Stage1-vs-Stage2 |
1.678370E-01 |
| Stage1-vs-Stage3 |
1.607610E-01 |
| Stage1-vs-Stage4 |
2.936200E-01 |
| Stage2-vs-Stage3 |
7.419600E-01 |
| Stage2-vs-Stage4 |
6.177000E-01 |
| Stage3-vs-Stage4 |
8.416000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.24265050974282E-12 |
| Normal-vs-AfricanAmerican |
1.638200E-03 |
| Normal-vs-Asian |
1.96530000051709E-07 |
| Caucasian-vs-AfricanAmerican |
3.234800E-01 |
| Caucasian-vs-Asian |
9.017200E-01 |
| AfricanAmerican-vs-Asian |
3.123400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.13850000538207E-08 |
| Normal-vs-Female |
3.68719998977696E-09 |
| Male-vs-Female |
4.669600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.90789999541397E-08 |
| Normal-vs-Age(41-60Yrs) |
7.5744999161742E-10 |
| Normal-vs-Age(61-80Yrs) |
3.26490001700819E-09 |
| Normal-vs-Age(81-100Yrs) |
5.878800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.169700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.949900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.765400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.200000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.733800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.021200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.552300E-02 |
| Classical-VS-Follicular |
3.599000E-04 |
| Classical-VS-Other |
3.955200E-01 |
| Classical-VS-Normal |
6.19379999955427E-07 |
| Tall-VS-Follicular |
5.161400E-01 |
| Tall-VS-Other |
9.991200E-01 |
| Tall-VS-Normal |
3.42439999689859E-08 |
| Follicular-VS-Other |
7.312200E-01 |
| Follicular-VS-Normal |
1.54700030563504E-10 |
| Other-VS-Normal |
7.341400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.100100093827E-10 |
| Normal-vs-N1 |
1.4080999999333E-07 |
| N0-vs-N1 |
6.125200E-01 |
|
|
